ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.24B
Enterprise Value 31.3B
Trailing P/E N/A
Forward P/E 1-8.61
PEG Ratio (5 yr expected) 1-0.28
Price/Sales (ttm)N/A
Price/Book (mrq)7.06
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.14

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-46.87%
Return on Equity (ttm)-87.67%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -182.38M
Net Income Avi to Common (ttm)-179.66M
Diluted EPS (ttm)-6.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)159.22M
Total Cash Per Share (mrq)5.94
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.98
Book Value Per Share (mrq)6.56

Cash Flow Statement

Operating Cash Flow (ttm)-154.82M
Levered Free Cash Flow (ttm)-89.14M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.19
52-Week Change 34.84%
S&P500 52-Week Change 36.14%
52 Week High 382.68
52 Week Low 333.06
50-Day Moving Average 347.45
200-Day Moving Average 344.79

Share Statistics

Avg Vol (3 month) 3717.93k
Avg Vol (10 day) 31.02M
Shares Outstanding 526.81M
Float 21.17M
% Held by Insiders 15.02%
% Held by Institutions 1121.66%
Shares Short (Oct 31, 2018) 45.7M
Short Ratio (Oct 31, 2018) 47.12
Short % of Float (Oct 31, 2018) 423.50%
Short % of Shares Outstanding (Oct 31, 2018) 421.26%
Shares Short (prior month Sep 28, 2018) 45.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A